24 July 2017, SomnoMed Limited (ASX:SOM) announced today that a return to growth of sales in the US during the quarter (+24% over prior year), combined with ongoing strong Q4 growth in Europe (+20.6%), resulted in record total group unit quarterly sales of 19,859 units (+24.2%). Total device sales for the 2016/17 year were 68,100 units. Unaudited quarterly group revenues were $14.3 million (+22%) and total group revenues for the 2016/17 financial year were $49.3 million, representing an annual growth of +12%.
Renew Sleep Solutions (“RSS”) opened its seventh centre during the month of June, to end its first 7 months of trading with an exceptional operational performance. “The latest centre in Phoenix, Arizona continues our commitment to expand our network of treatment outlets across the US and I am very proud of our team and their achievements during this time,” commented Mr Jim Evanger, CEO of RSS. “We remain confident that this “Direct To Patient” initiative will continue to build in line with or above our current expectations in terms of patient inquiries, appointments and treatments,” Mr Evanger added.
For further information please download PDF attached:
Download this document
